The United Kingdom Prospective Diabetes Study (UKPDS) studied >1000 patients and found a decrease in DR progression with an ACE inhibitor and a β1-adrenergic receptor antagonist, suggesting that the effect may due to mitigated hypertension rather than an ACE inhibitor-specific effect [129]. This evidence concerns the gene ACE and diabetes mellitus.